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By now, one hardly needs to stress the 
importance of solar UVR in the etiol-
ogy of cutaneous squamous and basal 
cell carcinomas. What is less well 
understood, however, is the nature and 
magnitude of variables that influence 
the effectiveness of a given cumulative 
exposure in eliciting the tumor response 
in a susceptible population (let alone in 
a given individual).
The concern with emollients is not 
altogether new. Over several decades, a 
substantial number of published papers 
from clinical studies have suggested that 
there is a small but measurable influ-
ence of applied vehicles on cutaneous 
response to UVR exposure. For example, 
clinical data indicate that “application 
of typical cosmetic moisturizers con-
taining 10% mineral oil or 10% glycerin 
decreased average MED (minimum ery-
themal dose) 5 or 7.6%, respectively” 
(TKL Research, 1995). Demonstrating 
differences of such magnitude would 
require a large sampling base, and the 
differences would almost certainly be 
undetectable in studies involving limited 
numbers of individuals.
Although cosmetic creams and oils 
appear to enhance UVR penetration to 
a small degree, the heavier greases may 
have the opposite effect in human skin. 
For example, Schleider et al. (1979) 
observed that peanut oil and corn oil 
had no effect, mineral oil and Alpha 
Keri bath oil had a minimal effect, and 
Vaseline or petrolatum substantially 
reduced the effectiveness of UVR in 
eliciting erythema.
A physical–optical basis for a vehi-
cle’s effects in human skin has been 
described by Anderson and Parrish 
(1981, 1982). They indicated that pro-
longed application of water or aqueous 
media to normal Caucasian skin results 
in an “increase in transmittance of UV... 
[and] an increase in sensitivity...with a 
40–50% decrease in MED...in contrast, 
lipophylic substances such as mineral 
oil neither extract significant amounts of 
UV-absorbing material...nor affect the 
MED to UVB radiation when applied in 
vivo.” They also conclude that “mineral 
oil, which readily spreads over the sur-
face of skin...does little to reduce reflec-
tance” (or increase penetration) in nor-
mal skin, but may have some effect in 
the thicker corneum of psoriatic plaque. 
In contrast, Hudson-Peacock et al. 
(1994) found a greater epidermal trans-
mission of UVR in vitro after application 
of some oily substances.
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Topically applied formulations (e.g., emollients and moisturizers) may influence 
the optical physics of skin and therefore the effectiveness of UVR exposures. In 
this issue, Lu et al. provide evidence for another type of influence by moistur-
izers, one that does not require the presence of the chemical agent before or 
during UVR exposure. Several such test agents applied after the completion of 
a course of UVR enhanced the tumor response in mice, both qualitatively and 
quantitatively. The study design is rational but the group sizes are modest, the 
resulting database is therefore limited, and the repeatability is not yet deter-
mined. Perhaps most important for the this Journal's readership, the clinical rel-
evance is unknown and deserves detailed examination.
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Leroy et al. (1986) measured changes 
in the transmission spectrum through 
untreated versus oiled dried suction blis-
ter epidermis (they apparently did not 
also investigate hydrated suction blister 
epidermis). The investigators claimed 
that the in vitro findings were consistent 
with better psoriatic clearing clinically.
Gahard et al. (1996) proposed that 
emollients changed the skin response 
enough to make a substantial difference 
to the patients undergoing phototherapy. 
Leroy et al. (1986) reported increased 
penetration by high-intensity UV rays 
following the application of Vaseline oil. 
Schleider et al. (1979) found a minimal 
effect by lighter oils and some protec-
tion by heavier greases such as petrola-
tum. Farr et al. (1983) provided evidence 
of vehicle-induced increase in in vivo 
transmission of light through psoriatic 
plaques, including a twofold transmis-
sion increase with glycerin.
As indicated by Lu and colleagues 
(2009, this issue), Kligman and Kligman 
(1992) found protection by Vaseline 
against both acute and chronic effects 
of UVR, including tumorigenesis, but 
they reported substantial enhancement 
of acute photoirritation as well as tum-
origenesis by mineral oil. Although they 
acknowledged some optical effect by 
emollients, they disclaimed the idea that 
the effect was entirely physical/optical.
Taken together, the published data 
provide substantial evidence that 
some vehicles, particularly the lighter 
oils, enhance penetration of UVR into 
mouse skin, leading to a greater cuta-
neous response—sometimes nearly 
doubling the effectiveness of a UVR 
dose. A qualitatively similar effect is 
sometimes evident in human skin, but 
the enhancement is usually marginal.
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Prior to the report by Lu et al., little 
attention was paid to the possibility of 
a post-UVR effect by these seemingly 
innocuous formulations. Their paper rais-
es the question of whether these agents 
belong on a list of more active com-
pounds analogous to tumor promoters (in 
two-stage carcinogenesis, in which UVR 
is the initiator; see Forbes et al., 1979; 
Sambuco and Forbes, 1983). Beyond the 
interest in Lu and colleagues’ challenging 
laboratory data is the obvious question 
of relevance to humans. Animal studies 
are critical to hazard identification but 
are still lacking as a risk-assessment tool 
(Forbes and Sambuco, 1988). More spe-
cifically, for such studies to provide guid-
ance on estimating the possible impact 
on humans, dose–response (“calibra-
tion”) treatment groups are needed with 
which to calculate “potency factors” 
(Forbes et al., 2003). When available, 
calibration treatment groups provide 
a dynamic range of responses to UVR 
alone, permitting accurate interpolation 
and reasonable extrapolation for data 
from the groups also receiving the test 
agents. If significant differences are found 
between treatment groups and the cor-
responding calibration group, then cal-
culating a scaling factor or potency ratio 
may provide a measure of the effective-
ness of each treatment, i.e., an estimated 
ratio of UVR doses to produce the same 
response (Forbes et al., 2003). Restated, 
deviations from a “zero-effect” level 
in tumor response can be expressed in 
terms of a potency factor (i.e., expressed 
as the mathematical equivalent of chang-
ing the UV dose by a specified fraction). 
One can only hope that such experimen-
tal data will become available from addi-
tional studies, particularly in view of the 
findings of Lu et al. (2009).
Clinical data that can be used to 
evaluate the possible relevance of Lu 
and colleagues’ findings to humans 
will not be easy to extract, although an 
analogous question about another type 
of interaction was answered recently by 
Karagas et al. (2007). They presented evi-
dence that the use of recognized photo-
sensitizing agents can increase skin can-
cer incidence in patients requiring these 
mediations (as compared with others in 
the general population). Their approach 
may suggest a methodology for use in 
the current context.
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Macrophage Inhibitory cytokine-1:  
A new Player  
in Melanoma Development
Toshiharu Yamashita1, Akihiro Yoneta1 and Tokimasa Hida1
Macrophage inhibitory cytokine-1 (MIc-1) is a divergent member of the TGf-β 
superfamily. Although it has been reported to exhibit both tumorigenic and 
antitumorigenic activities, Boyle et al. report in this issue that MIc-1 expression 
was correlated with the tumorigenicity of melanoma cells. The elucidation of 
signaling pathways around MIc-1 might contribute to prospective targeting 
therapy for melanoma.
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MIC-1, also called placental bone mor-
phogenetic protein, prostate-derived 
factor, growth differentiation factor 15, 
and nonsteroidal anti-inflammatory 
drug-activated gene, was independently 
cloned by four groups from cDNA 
libraries of monocytoid cell line U937, 
placenta, and spleen. Its predicted 
